cost-effectiveness research

Research in Review

Carfilzomib Cost Effective for Myeloma Treatment

06/01/2016

JCP Editors

Carfilzomib, in combination with lenalidomide and dexamethasone (KRd), may be a cost-effective treatment option for patients with relapsed or refractory multiple myeloma, according to the Kyprolis Global Economic...

...

06/01/2016

Journal of Clinical Pathways

Research in Review

Increasing Use of Percutaneous Liver Biopsy Accompanied by Growing Costs

05/06/2016

JCP Editors

A study of image-guided percutaneous liver biopsy (PLB) in patients with hepatocellular carcinoma has found that the procedure is increasingly being used in recent years despite safety concerns as well as rising...

...

05/06/2016

Journal of Clinical Pathways

Research in Review

Co-Testing a More Cost-Effective Screening Strategy for Cervical Cancer Than HPV Primary

04/01/2016

JCP Editors

A model developed using data from health care databases and published literature has found that Pap plus human papillomavirus (HPV) mRNA testing that includes genotying for HPV 16 and 18 may be a more effective...

A...

04/01/2016

Journal of Clinical Pathways

Research in Review

Gene-Expression Test Cost-Effective for Determining Unknown Tumor Origins

03/31/2016

JCP Editors

The 2000-gene-expression profiling (GEP) test may be a more cost-effective option than current strategies for identifying tumor origin in patients with cancer of unknown primary (CUP), a recent study...

The...

03/31/2016

Journal of Clinical Pathways

Research in Review

PET-CT Scans More Cost-Effective Than Surgery for Head and Neck Cancer

03/28/2016

JCP Editors

Surveillance using positron emission tomography-computed tomography (PET-CT) scans can be a cost-effective and safe alternative to invasive neck dissection for certain patients with head and neck cancer (HNC),...

...

03/28/2016

Journal of Clinical Pathways

Research in Review

Imatinib Projected to Be Most Cost-Effective Option for CML

03/14/2016

JCP Editors

According to researchers, imatinib is projected to become the most cost-effective initial treatment strategy for patients with chronic myeloid leukemia in chronic phase (CML-CP) after its patent expires later this...

...

03/14/2016

Journal of Clinical Pathways

Research in Review

Stereotactic Body Radiation More Cost-Effective for Treating Prostate Cancer Than Standard Therapy

03/08/2016

JCP Editors

Stereotactic body radiotherapy (SBRT) with a robotic system is currently more cost-effective than standard regimens as well as SBRT delivered with other systems for the treatment of prostate cancer, according to a...

...

03/08/2016

Journal of Clinical Pathways

Research in Review

Multiple-Treatment Regimens for Colorectal Cancer Have High Costs and Little Benefit to Elderly Patients

03/02/2016

JCP Editors

A 10-year study has found that the rate of elderly patients receiving 3 or more treatments for metastatic colorectal cancer has increased substantially from 2000 to 2009, but that added agents may not lead to...

A...

03/02/2016

Journal of Clinical Pathways

Research in Review

Health Information Exchange Reduces Unnecessary Imaging, Lowers Costs

02/16/2016

JCP Editors

Access to an electronic health information exchange (HIE) system can reduce costs associated with unnecessary repeated imaging tests, claims a new study.  Imaging procedures such as x-rays or ultrasounds...

Access...

02/16/2016

Journal of Clinical Pathways

Research in Review

Higher Doses of Radiation Therapy Effective and Safe for Patients With NSCLC

02/02/2016

JCP Editors

Precision hypofractionated radiation therapy (RT) may be a potent alternative for patients with non-small cell lung cancer (NSCLC) who cannot receive chemotherapy due to the potential for severe side...

...

02/02/2016

Journal of Clinical Pathways